Browse All
Displaying 1 - 2 of 2
Author:Vermersch, Patrick Granziera, Cristina Mao-Draayer, Yang Cutter, Gary Kalbus, Oleksandr Staikov, Ivan Dufek, Michal Montalban, Xavier Krieger, Stephen Saubadu, Stephane Luo, Xiaodong Smyth, Brendan Djukic, Biljana Truffinet, Philippe Wallstroem, Erik Giov,
Session Name:S3: Multiple Sclerosis: Clinical Trials
Topic:Multiple Sclerosis
Program Number:S3.006
Author Institution:University of Lille, Inserm U1172 LilNCog, CHU Lille, FHU Precise, Lille, France , Lille, France Translational Imaging in Neurology (ThINk) Basel, Department of Biomedical Engineering, Faculty of Medicine Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Basel, Switzerland, Basel, Switzerland Autoimmunity Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA, Oklahoma City, OK Department of Biostatistics, UAB School of Public Health, Birmingham, AL, USA, Birmingham, AL Department of Neurology, Dnipro State Medical University, Dnipro, Ukraine, Dnipro, Ukraine Clinic of Neurology and Sleep Medicine, Acibadem City Clinic University Hospital Tokuda, Sofia, Bulgaria, Sofia, Bulgaria First Department of Neurology, St. Anne’s University Hospital, Faculty of Medicine, Masaryk University, Brno, Czech Republic, Brno, Czech Republic Multiple Sclerosis Centre of Catalonia, Department of Neurology, Vall d'Hebron University Hospital, Barcelona, Spain , Barcelona, Spain Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Icahn School of Medicine at Mount Sinai, New York, NY, USA, New York, NY Sanofi, Gentilly, France, Gentilly, France Sanofi, Bridgewater, NJ, USA, Bridgewater, NJ Sanofi, Cambridge, MA, USA, Cambridge, MA Queen Mary University of London, London, United Kingdom , London, United Kingdom
Author:Fox, Robert J. Bar-Or, Amit Traboulsee, Anthony Oreja-Guevara, Celia Giovannoni, Gavin Vermersch, Patrick Syed, Sana Li, Ye Vargas, Wendy S. Turner, Timothy J. Wallstroem, Erik Reich, Daniel S.
Session Name:PL5: Clinical Trials Plenary Session
Program Number:PL5.003
Author Institution:Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, United States, Cleveland, OH Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, University of Pennsylvania, Philadelphia, United States, Philadelphia, PA The University of British Columbia, Division of Neurology, Vancouver, Canada, Vancouver, BC, Canada Multiple Sclerosis Center, University Hospital San Carlos, Madrid, Spain, Madrid, Spain Queen Mary University London, Blizard Institute, Barts and The London School of Medicine and Dentistry, London, United Kingdom, London, United Kingdom University of Lille, Inserm U1172, CHU Lille, FHU Precise, Lille, France, Lille, France Sanofi, Cambridge, United States, Cambridge, MA Sanofi, Bridgewater, United States, Bridgewater, NJ Translational Neuroradiology Section, National Institutes of Health, Bethesda, United States, Bethesda, MD
